<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190427043397N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-07-26</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>effect of respiratory and mobility exercise on pain, anxiety and lung expansion in post surgery patients with cancer</public_title>
      <acronym></acronym>
      <scientific_title>Effect of concurrent respiratory workout and mobility exercises on pain, anxiety and lung expansion ability in post-operative lung cancer surgery patients with chest tube</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>81</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/39155</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>lung cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: On the first visit with the patients (before surgery and installation of chest tubes) explanations about interventions and the research was given to them, then the informed consent was signed by the patient and demographic information form was filled out by the researcher. The spirometry results was observed and recorded from patient’s file. Before the operation, when patient was present in the ward, and after filling forms mentioned above, instructions for respiratory workout and mobility exercises including diaphragmatic respiration, pursed lip breathing, chest physiotherapy, physical movements for arm and shoulder of the side that chest tube has been installed (whether its left or right) and using incentive spirometer were given to the patient. These instructions were conducted and controlled by the researcher. After the surgery was finished and patient was transferred to the ward, pain and anxiety were measured using visual analog scale (VAS). A checklist was given to the participant which contained all workouts that he/she was meant to do and asked to fill the checklist each time doing the exercises in order to ensure that they perform exercises correctly. The researcher controlled the checklist in order to make sure that no exercise has been missed. Participants were supposed to do the exercises ten times in one hour according to ability and clinical conditions. Therefore, participants performed each exercise that could do until it reaches ten times in one hour and doesn’t make him/her tired. These activities were performed once each day on certain hours (10 AM to 12 MD) with presence of the researcher until chest tube was removed and VAS marks for pain and anxiety were written down. Intervention 2: Control group: On the first visit with the patients (before surgery and installation of chest tubes) explanations about interventions and the research was given to them, then the informed consent was signed by the patient and demographic information form was filled out by the researcher. The spirometry results was observed and recorded from patient’s file. There were no research related instructions given to the patients of control group. After the surgery was finished and patient was transferred to the ward, pain and anxiety were measured using visual analog scale (VAS). Pain and anxiety were measured daily on certain hours (10 AM to 12 MD) until the tubes were removed. Before the removal of the chest tubes another spirometry test was token from the patients and results were recorded.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is because of financial problems and costs</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Arman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat st. Tohid sq</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1417653761</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>alirezaarman20@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Arman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat st. Tohid sq</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1417653761</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>alirezaarman20@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>having 2 chest tubes installed
over 18 years old
completely aware of time, place and who he/she is
not taking Narcotic drugs at least 4 hours before the interventions
no sensory disorders (audio and visual)
no substance addiction
not taking anti anxiety drugs
no history of lung diseases and no history of chest tube installation</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>severe anxiety due to environmental factors
not being interested to participate
lack of learning ability
addiction</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C34.90</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant neoplasm of unspecified part of unspecified bronchus or lung</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: On the first visit with the patients (before surgery and installation of chest tubes) explanations about interventions and the research was given to them, then the informed consent was signed by the patient and demographic information form was filled out by the researcher. The spirometry results was observed and recorded from patient’s file. Before the operation, when patient was present in the ward, and after filling forms mentioned above, instructions for respiratory workout and mobility exercises including diaphragmatic respiration, pursed lip breathing, chest physiotherapy, physical movements for arm and shoulder of the side that chest tube has been installed (whether its left or right) and using incentive spirometer were given to the patient. These instructions were conducted and controlled by the researcher. After the surgery was finished and patient was transferred to the ward, pain and anxiety were measured using visual analog scale (VAS). A checklist was given to the participant which contained all workouts that he/she was meant to do and asked to fill the checklist each time doing the exercises in order to ensure that they perform exercises correctly. The researcher controlled the checklist in order to make sure that no exercise has been missed. Participants were supposed to do the exercises ten times in one hour according to ability and clinical conditions. Therefore, participants performed each exercise that could do until it reaches ten times in one hour and doesn’t make him/her tired. These activities were performed once each day on certain hours (10 AM to 12 MD) with presence of the researcher until chest tube was removed and VAS marks for pain and anxiety were written down.</i_keyword>
      <i_keyword>Control group: On the first visit with the patients (before surgery and installation of chest tubes) explanations about interventions and the research was given to them, then the informed consent was signed by the patient and demographic information form was filled out by the researcher. The spirometry results was observed and recorded from patient’s file. There were no research related instructions given to the patients of control group. After the surgery was finished and patient was transferred to the ward, pain and anxiety were measured using visual analog scale (VAS). Pain and anxiety were measured daily on certain hours (10 AM to 12 MD) until the tubes were removed. Before the removal of the chest tubes another spirometry test was token from the patients and results were recorded.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Lung expansion mark on spirometry. Timepoint: Before interventing - after interventin (before removing chest tube). Method of measurement: Spirometry.</prim_outcome>
      <prim_outcome>Measured pain using visual analog scale. Timepoint: Everyday until chest tube removal. Method of measurement: Visual Analogue Scale for pain.</prim_outcome>
      <prim_outcome>Measured anxiety using visual analog scale. Timepoint: Everyday until chest tube removal. Method of measurement: Visual Analogue Scale for anxiety.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-10-27</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Tehran University of Medical Sciences, Qods street, Keshavarz boulevard Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
